(Q40413623)

20 September 2017

title

Long-term expression of erythropoietin from myoblasts immobilized in biocompatible and neovascularized microcapsules (English)

1 reference

20 September 2017

0 references

1 reference

1 reference

7

1 reference

20 September 2017

6

0 references

author name string

G Orive

1

1 reference

20 September 2017

M De Castro

2

1 reference

20 September 2017

S Ponce

3

1 reference

20 September 2017

R M Hernández

4

1 reference

20 September 2017

A R Gascón

5

1 reference

20 September 2017

José L Pedraz

8

1 reference

20 September 2017

publication date

1 August 2005

1 reference

20 September 2017

1 reference

20 September 2017

volume

12

1 reference

20 September 2017

issue

2

1 reference

20 September 2017

page(s)

283-289

1 reference

Cell encapsulation: promise and progress

20 September 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMTHE.2005.04.002

Technology of mammalian cell encapsulation

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMTHE.2005.04.002

Therapeutic applications of polymeric artificial cells

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMTHE.2005.04.002

Cell-based therapies go live

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMTHE.2005.04.002

A highly sensitive cell assay for validation of purification regimes of alginates

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMTHE.2005.04.002

Effect of poly-L-lysine coating on macrophage activation by alginate-based microcapsules: assessment using a new in vitro method.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMTHE.2005.04.002

An encapsulation system for the immunoisolation of pancreatic islets

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMTHE.2005.04.002

Microencapsulation of living cells in semi-permeable membranes with covalently cross-linked layers

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMTHE.2005.04.002

Microencapsulated genetically engineered live E. coli DH5 cells administered orally to maintain normal plasma urea level in uremic rats

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMTHE.2005.04.002

Continuous release of endostatin from microencapsulated engineered cells for tumor therapy

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMTHE.2005.04.002

Biocompatibility of microcapsules for cell immobilization elaborated with different type of alginates

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMTHE.2005.04.002

Survival of different cell lines in alginate-agarose microcapsules

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMTHE.2005.04.002

Biocompatibility Evaluation of Different Alginates and Alginate-Based Microcapsules

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMTHE.2005.04.002

Microencapsulated islets as bioartificial endocrine pancreas

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMTHE.2005.04.002

Continuous delivery of human and mouse erythropoietin in mice by genetically engineered polymer encapsulated myoblasts

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMTHE.2005.04.002

Human-compatible collagen matrix for prolonged and reversible systemic delivery of erythropoietin in mice from gene-modified marrow stromal cells

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMTHE.2005.04.002

Long-term doxycycline-regulated secretion of erythropoietin by encapsulated myoblasts

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMTHE.2005.04.002

Production of purified alginates suitable for use in immunoisolated transplantation

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMTHE.2005.04.002

Biocompatible alginate from freshly collected Laminaria pallida for implantation

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMTHE.2005.04.002

Studies on small (<350 microm) alginate-poly-L-lysine microcapsules. III. Biocompatibility Of smaller versus standard microcapsules

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMTHE.2005.04.002

Xenografts of rat islets into diabetic mice. An evaluation of new smaller capsules

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMTHE.2005.04.002

Prevention of the initial host immuno-inflammatory response determines the long-term survival of encapsulated myoblasts genetically engineered for erythropoietin delivery

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMTHE.2005.04.002

Considerations for successful transplantation of encapsulated pancreatic islets

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMTHE.2005.04.002

Optimization of human erythropoietin secretion from MLV-infected human primary fibroblasts used for encapsulated cell therapy.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMTHE.2005.04.002

Therapeutic use of continuous subcutaneous infusion of recombinant human erythropoietin in malnourished predialysis anemic patients with diabetic nephropathy

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMTHE.2005.04.002

Macrophage overgrowth affects neighboring nonovergrown encapsulated islets

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMTHE.2005.04.002

Erythropoietin prevents early and late neuronal demise through modulation of Akt1 and induction of caspase 1, 3, and 8.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMTHE.2005.04.002

Erythropoietin fosters both intrinsic and extrinsic neuronal protection through modulation of microglia, Akt1, Bad, and caspase-mediated pathways

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMTHE.2005.04.002

Central Nervous System Frontiers for the Use of Erythropoietin

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMTHE.2005.04.002

Efficient and stable adeno-associated virus-mediated transduction in the skeletal muscle of adult immunocompetent mice

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMTHE.2005.04.002

Regulated expression of erythropoietin from an AAV vector safely improves the anemia of beta-thalassemia in a mouse model.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMTHE.2005.04.002

Improvement of mouse beta-thalassemia upon erythropoietin delivery by encapsulated myoblasts

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMTHE.2005.04.002

Erythropoietin: structure, control of production, and function

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMTHE.2005.04.002

10.1016/J.YMTHE.2005.04.002

7 January 2021

Identifiers

DOI

1 reference

20 September 2017

1 reference